An interesting early paper showed that localization of FLNA also bears biomarker potential in prostate cancer since cytoplasmic localization of FLNA was shown to correlate with metastasis [395], and potentiation of FLNA nuclear localization was even suggested to enhance the effectiveness of androgen deprivation therapy [396]. The gene discussed is FLNA; the disease is prostate carcinoma.